Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

Episode 6,  Jul 06, 08:11 PM

During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer.

Fátima Cardoso, MD
Director, Breast Unit
Champalimaud Clinical Center
Lisbon, Portugal

Mario Campone, MD, PhD
Chief Executive Officer
Institut de Cancérologie de l’Ouest (ICO)
Angers, France

Giuseppe Viale, MD, FRCPath
Department of Pathology
University of Milan
Milan, Italy